Literature DB >> 34193990

Malaria vaccine gets a parasite boost in the liver.

Nana K Minkah, Stefan H I Kappe.   

Abstract

Entities:  

Keywords:  Immunology; Malaria; Medical research

Mesh：

Substances：

Year:  2021        PMID： 34193990     DOI： 10.1038/d41586-021-01720-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Authors:  Mahamadou S Sissoko; Sara A Healy; Abdoulaye Katile; Freda Omaswa; Irfan Zaidi; Erin E Gabriel; Bourama Kamate; Yacouba Samake; Merepen A Guindo; Amagana Dolo; Amadou Niangaly; Karamoko Niaré; Amatigue Zeguime; Kourane Sissoko; Hama Diallo; Ismaila Thera; Kelly Ding; Michael P Fay; Elise M O'Connell; Thomas B Nutman; Sharon Wong-Madden; Tooba Murshedkar; Adam J Ruben; Minglin Li; Yonas Abebe; Anita Manoj; Anusha Gunasekera; Sumana Chakravarty; B Kim Lee Sim; Peter F Billingsley; Eric R James; Michael Walther; Thomas L Richie; Stephen L Hoffman; Ogobara Doumbo; Patrick E Duffy
Journal:  Lancet Infect Dis       Date:  2017-02-16       Impact factor: 25.071

Review 2.  Designer Parasites: Genetically Engineered Plasmodium as Vaccines To Prevent Malaria Infection.

Authors:  Debashree Goswami; Nana K Minkah; Stefan H I Kappe
Journal:  J Immunol       Date:  2019-01-01       Impact factor: 5.422

3.  Specificity of protection of man immunized against sporozoite-induced falciparum malaria.

Authors:  D F Clyde; V C McCarthy; R M Miller; R B Hornick
Journal:  Am J Med Sci       Date:  1973-12       Impact factor: 2.378

4.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

5.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Authors: 
Journal:  Lancet       Date:  2015-04-23       Impact factor: 79.321

6.  Genome sequence of the human malaria parasite Plasmodium falciparum.

Authors:  Malcolm J Gardner; Neil Hall; Eula Fung; Owen White; Matthew Berriman; Richard W Hyman; Jane M Carlton; Arnab Pain; Karen E Nelson; Sharen Bowman; Ian T Paulsen; Keith James; Jonathan A Eisen; Kim Rutherford; Steven L Salzberg; Alister Craig; Sue Kyes; Man-Suen Chan; Vishvanath Nene; Shamira J Shallom; Bernard Suh; Jeremy Peterson; Sam Angiuoli; Mihaela Pertea; Jonathan Allen; Jeremy Selengut; Daniel Haft; Michael W Mather; Akhil B Vaidya; David M A Martin; Alan H Fairlamb; Martin J Fraunholz; David S Roos; Stuart A Ralph; Geoffrey I McFadden; Leda M Cummings; G Mani Subramanian; Chris Mungall; J Craig Venter; Daniel J Carucci; Stephen L Hoffman; Chris Newbold; Ronald W Davis; Claire M Fraser; Bart Barrell
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

7.  Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Authors:  Mehreen S Datoo; Magloire H Natama; Athanase Somé; Ousmane Traoré; Toussaint Rouamba; Duncan Bellamy; Prisca Yameogo; Daniel Valia; Moubarak Tegneri; Florence Ouedraogo; Rachidatou Soma; Seydou Sawadogo; Faizatou Sorgho; Karim Derra; Eli Rouamba; Benedict Orindi; Fernando Ramos Lopez; Amy Flaxman; Federica Cappuccini; Reshma Kailath; Sean Elias; Ekta Mukhopadhyay; Andres Noe; Matthew Cairns; Alison Lawrie; Rachel Roberts; Innocent Valéa; Hermann Sorgho; Nicola Williams; Gregory Glenn; Louis Fries; Jenny Reimer; Katie J Ewer; Umesh Shaligram; Adrian V S Hill; Halidou Tinto
Journal:  Lancet       Date:  2021-05-05       Impact factor: 202.731

Review 8.  Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.

Authors:  Thomas L Richie; Peter F Billingsley; B Kim Lee Sim; Eric R James; Sumana Chakravarty; Judith E Epstein; Kirsten E Lyke; Benjamin Mordmüller; Pedro Alonso; Patrick E Duffy; Ogobara K Doumbo; Robert W Sauerwein; Marcel Tanner; Salim Abdulla; Peter G Kremsner; Robert A Seder; Stephen L Hoffman
Journal:  Vaccine       Date:  2015-11-27       Impact factor: 3.641

9.  Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.

Authors:  Zita Sulyok; Rolf Fendel; Stephen L Hoffman; Benjamin Mordmüller; Peter G Kremsner; Bianca Eder; Freia-Raphaella Lorenz; Natasha Kc; Matthias Karnahl; Albert Lalremruata; The T Nguyen; Jana Held; Folashade Almeine Cyntiche Adjadi; Torsten Klockenbring; Judith Flügge; Tamirat Gebru Woldearegai; Carlos Lamsfus Calle; Javier Ibáñez; Miriam Rodi; Diane Egger-Adam; Andrea Kreidenweiss; Carsten Köhler; Meral Esen; Mihály Sulyok; Anita Manoj; Thomas L Richie; B Kim Lee Sim
Journal:  Nat Commun       Date:  2021-05-04       Impact factor: 14.919

10.  PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.

Authors:  Sean C Murphy; Gregory A Deye; B Kim Lee Sim; Shirley Galbiati; Jessie K Kennedy; Kristen W Cohen; Sumana Chakravarty; Natasha Kc; Yonas Abebe; Eric R James; James G Kublin; Stephen L Hoffman; Thomas L Richie; Lisa A Jackson
Journal:  PLoS Pathog       Date:  2021-05-28       Impact factor: 6.823
View more
  2 in total

Review 1.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

2.  Evaluation of sustainable susceptibility to Plasmodium vivax infection among colonized Anopheles darlingi and Anopheles deaneorum.

Authors:  Najara A C Santos; Alice O Andrade; Thais C Santos; Leandro N Martinez; Amália S Ferreira; Alessandra S Bastos; Mirilene M Martins; José D C Pontual; Carolina B G Teles; Jansen F Medeiros; Maisa S Araújo
Journal:  Malar J       Date:  2022-06-03       Impact factor: 3.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.